ArticleDrug delivery2017

Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics.

Haibin Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.